Your browser doesn't support javascript.
loading
Intein-mediated cytoplasmic reconstitution of a split toxin enables selective cell ablation in mixed populations and tumor xenografts.
Purde, Vedud; Kudryashova, Elena; Heisler, David B; Shakya, Reena; Kudryashov, Dmitri S.
  • Purde V; Department of Chemistry and Biochemistry, The Ohio State University, Columbus, OH 43210.
  • Kudryashova E; The Ohio State Biochemistry Program, The Ohio State University, Columbus, OH 43210.
  • Heisler DB; Department of Chemistry and Biochemistry, The Ohio State University, Columbus, OH 43210; kudryashova.1@osu.edu kudryashov.1@osu.edu.
  • Shakya R; Department of Chemistry and Biochemistry, The Ohio State University, Columbus, OH 43210.
  • Kudryashov DS; The Ohio State Biochemistry Program, The Ohio State University, Columbus, OH 43210.
Proc Natl Acad Sci U S A ; 117(36): 22090-22100, 2020 09 08.
Article en En | MEDLINE | ID: mdl-32839344
ABSTRACT
The application of proteinaceous toxins for cell ablation is limited by their high on- and off-target toxicity, severe side effects, and a narrow therapeutic window. The selectivity of targeting can be improved by intein-based toxin reconstitution from two dysfunctional fragments provided their cytoplasmic delivery via independent, selective pathways. While the reconstitution of proteins from genetically encoded elements has been explored, exploiting cell-surface receptors for boosting selectivity has not been attained. We designed a robust splitting algorithm and achieved reliable cytoplasmic reconstitution of functional diphtheria toxin from engineered intein-flanked fragments upon receptor-mediated delivery of one of them to the cells expressing the counterpart. Retargeting the delivery machinery toward different receptors overexpressed in cancer cells enables selective ablation of specific subpopulations in mixed cell cultures. In a mouse model, the transmembrane delivery of a split-toxin construct potently inhibits the growth of xenograft tumors expressing the split counterpart. Receptor-mediated delivery of engineered split proteins provides a platform for precise therapeutic and experimental ablation of tumors or desired cell populations while also greatly expanding the applicability of the intein-based protein transsplicing.
Asunto(s)
Palabras clave

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Toxinas Bacterianas / Sistemas de Liberación de Medicamentos / Citoplasma / Inteínas / Neoplasias Tipo de estudio: Evaluation_studies Límite: Animals / Female / Humans Idioma: En Año: 2020 Tipo del documento: Article

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Toxinas Bacterianas / Sistemas de Liberación de Medicamentos / Citoplasma / Inteínas / Neoplasias Tipo de estudio: Evaluation_studies Límite: Animals / Female / Humans Idioma: En Año: 2020 Tipo del documento: Article